Trial intelligence / Profile preview

PPX with Temozolomide and Radiation for Newly Diagnosed Brain Tumors

NCT00763750Phase 2Completed

Start
Oct 2008
Primary completion
Jun 2011
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel poliglumex in glioblastoma (GBM), anaplastic glioma. Started Oct 2008; status: completed.

02

Drugs

paclitaxel poliglumex
03

Conditions

glioblastoma (GBM)anaplastic glioma

Beyond the preview

Go deeper on NCT00763750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00763750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call